University of Oxford, Oxford, UK.
Int J Cancer. 2012 Aug 15;131(4):930-7. doi: 10.1002/ijc.26460. Epub 2011 Nov 28.
Little is known about the etiology of in situ ductal breast cancer (DCIS) or what influences its possible progression to invasive ductal disease. Comparison of risk factors for DCIS and invasive ductal cancer may throw some light on these issues. We estimated relative risks for DCIS and invasive ductal breast cancer according to 12 genetic and eight environmental risk factors among 1.1 million postmenopausal women in a large prospective UK study. There was no strong evidence of a different association with DCIS versus invasive ductal cancer for any of the 12 susceptibility loci examined. We also found similar associations of age at menarche, age at first birth, parity, age at menopause, family history of breast cancer and use of hormone replacement therapy with DCIS and invasive ductal cancer. Only body mass index (BMI) showed a clear difference in association in that it was positively associated with the risk of invasive ductal cancer but not DCIS (RRs per 5 kg/m(2) = 1.20 and 1.01, respectively; p-value for heterogeneity = 0.002). The very similar risk factor profiles observed here for DCIS and invasive ductal cancer suggest that DCIS is a precursor of invasive ductal cancer and most risk factors affect the risk of invasive ductal cancer primarily through their effects on the risk of DCIS. The lack of association between BMI and DCIS suggests a greater influence of BMI on disease progression.
原位导管乳腺癌(DCIS)的病因知之甚少,也不知道哪些因素会影响其向浸润性导管疾病发展。比较 DCIS 和浸润性导管癌的危险因素可能会对这些问题有所启发。我们根据一项大型前瞻性英国研究中 110 万名绝经后妇女的 12 种遗传和 8 种环境危险因素,估计了 DCIS 和浸润性导管乳腺癌的相对风险。在检查的 12 个易感基因座中,没有证据表明与 DCIS 与浸润性导管癌之间存在不同的关联。我们还发现,初潮年龄、初产年龄、产次、绝经年龄、乳腺癌家族史和激素替代疗法与 DCIS 和浸润性导管癌的相关性相似。只有体重指数(BMI)的关联有明显差异,它与浸润性导管癌的风险呈正相关,但与 DCIS 无关(每增加 5kg/m2 的 RR 分别为 1.20 和 1.01;异质性 p 值=0.002)。在这里观察到的 DCIS 和浸润性导管癌的危险因素非常相似,这表明 DCIS 是浸润性导管癌的前兆,大多数危险因素主要通过其对 DCIS 风险的影响来影响浸润性导管癌的风险。BMI 与 DCIS 之间缺乏关联表明,BMI 对疾病进展的影响更大。